SAC Alzheimer's Drug Trade: $276 Million Profit

SAC Alzheimer's Drug Trade: $276 Million Profit Play

Nov. 21 (Bloomberg) -- Berenzweig Leonard Managing Partner Seth Berenzweig discusses the insider trading case surrounding SAC Capital. He speaks with Deirdre Bolton on Bloomberg Television's "Money Moves." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus